These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 10327904

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. In vivo short echo time 1H-magnetic resonance spectroscopic imaging (MRSI) of the temporal lobes.
    McLean MA, Woermann FG, Simister RJ, Barker GJ, Duncan JS.
    Neuroimage; 2001 Aug; 14(2):501-9. PubMed ID: 11467922
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate.
    Lyoo IK, Kong SW, Sung SM, Hirashima F, Parow A, Hennen J, Cohen BM, Renshaw PF.
    Psychiatry Res; 2003 Jun 30; 123(2):87-100. PubMed ID: 12850248
    [Abstract] [Full Text] [Related]

  • 27. Choline Compounds of the Frontal Lobe and Temporal Glutamatergic System in Bipolar and Schizophrenia Proton Magnetic Resonance Spectroscopy Study.
    Galińska-Skok B, Małus A, Konarzewska B, Rogowska-Zach A, Milewski R, Tarasów E, Szulc A, Waszkiewicz N.
    Dis Markers; 2018 Jun 30; 2018():3654894. PubMed ID: 30595760
    [Abstract] [Full Text] [Related]

  • 28. Neurometabolic functioning and neuropsychological correlates in children with ADHD-H: preliminary findings.
    Courvoisie H, Hooper SR, Fine C, Kwock L, Castillo M.
    J Neuropsychiatry Clin Neurosci; 2004 Jun 30; 16(1):63-9. PubMed ID: 14990761
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS.
    Pouwels PJ, Frahm J.
    Magn Reson Med; 1998 Jan 30; 39(1):53-60. PubMed ID: 9438437
    [Abstract] [Full Text] [Related]

  • 31. Glutamatergic and Neuronal Dysfunction in Gray and White Matter: A Spectroscopic Imaging Study in a Large Schizophrenia Sample.
    Bustillo JR, Jones T, Chen H, Lemke N, Abbott C, Qualls C, Stromberg S, Canive J, Gasparovic C.
    Schizophr Bull; 2017 May 01; 43(3):611-619. PubMed ID: 27550776
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Brain metabolite alterations in infants born preterm with intrauterine growth restriction: association with structural changes and neurodevelopmental outcome.
    Simões RV, Muñoz-Moreno E, Cruz-Lemini M, Eixarch E, Bargalló N, Sanz-Cortés M, Gratacós E.
    Am J Obstet Gynecol; 2017 Jan 01; 216(1):62.e1-62.e14. PubMed ID: 27667762
    [Abstract] [Full Text] [Related]

  • 34. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, Rothermundt M, Arolt V, Heindel W, Pfleiderer B.
    J Psychiatr Res; 2007 Oct 01; 41(8):625-34. PubMed ID: 16949099
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The effect of antidepressant treatment on N-acetyl aspartate levels of medial frontal cortex in drug-free depressed patients.
    Gonul AS, Kitis O, Ozan E, Akdeniz F, Eker C, Eker OD, Vahip S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan 01; 30(1):120-5. PubMed ID: 16236417
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.